Physician
Fantaci, Lindsay
Fantaci, Lindsay was paid $1.98M by Medicaid between Jan 2018 and May 2023, across 55 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 30% of everything it billed.
33Billing provider infoFANTACI, LINDSAY
MARRERO, LA 70072
MARRERO, LA 70072
33aNPI1225110406assigned 10/19/2006
33bProvider typePediatrics Physician
28Total paid$1.98M
24GClaims61,240
24DCodes billed55
24AFirst – last monthJan 2018 – May 2023
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#59 of 230
Median peer was paid$429K
This provider vs. median4.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,621 | $656K | |
| 2019 | 13,396 | $486K | |
| 2020 | 11,507 | $312K | |
| 2021 | 8,739 | $273K | |
| 2022 | 6,886 | $191K | |
| 2023 | 2,091 | $57K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 30% | 9,932 | 7,139 | $586K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 25% | 1,723 | 1,246 | $493K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 10% | 3,710 | 1,751 | $200K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.8% | 3,291 | 2,756 | $134K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 4.8% | 2,023 | 1,468 | $95K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4.0% | 3,095 | 2,563 | $79K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.3% | 3,512 | 3,071 | $46K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 2.1% | 208 | 132 | $41K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 5,725 | 4,383 | $34K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 1.6% | 1,644 | 1,485 | $32K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 2,968 | 2,270 | $30K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.5% | 516 | 447 | $29K |
43 more codes
| 80061 | Lipid panel | 1.3% | 2,716 | $26K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.2% | 403 | $24K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.2% | 444 | $23K |
| 54450 | <1% | 247 | $13K | |
| 99051 | <1% | 918 | $12K | |
| 92551 | <1% | 1,620 | $11K | |
| 69200 | <1% | 171 | $11K | |
| 99188 | <1% | 1,056 | $9K | |
| 82962 | <1% | 3,377 | $7K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 103 | $7K |
| 86308 | <1% | 1,321 | $5K | |
| 81002 | <1% | 2,391 | $5K | |
| 92567 | <1% | 449 | $5K | |
| 87634 | <1% | 76 | $4K | |
| J0720 | Injection, chloramphenicol sodium succinate, up to 1 gm | <1% | 296 | $3K |
| 87581 | <1% | 128 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 128 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 40 | $2K |
| 83655 | <1% | 216 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 296 | $2K |
| 99173 | <1% | 851 | $1K | |
| 69210 | <1% | 31 | $721.93 | |
| 90474 | <1% | 66 | $538.67 | |
| 81001 | <1% | 106 | $221.59 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 381 | $212.55 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 19 | $151.50 |
| 82948 | <1% | 15 | $28.44 | |
| 94760 | <1% | 897 | $14.51 | |
| 90716 | 0% | 84 | $0.00 | |
| 90686 | 0% | 1,173 | $0.00 | |
| 99000 | 0% | 92 | $0.00 | |
| 90680 | 0% | 120 | $0.00 | |
| 90744 | 0% | 12 | $0.00 | |
| 90700 | 0% | 782 | $0.00 | |
| 90713 | 0% | 491 | $0.00 | |
| 90685 | 0% | 163 | $0.00 | |
| 90670 | 0% | 491 | $0.00 | |
| 90649 | 0% | 14 | $0.00 | |
| 90648 | 0% | 413 | $0.00 | |
| 90707 | 0% | 99 | $0.00 | |
| 90633 | 0% | 162 | $0.00 | |
| 90715 | 0% | 12 | $0.00 | |
| 94150 | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.